Press
Release

Bayer MaterialScience Extends its Biomaterials Product Line

Bayer MaterialScience supplies innovative biomaterials for medical technology under the brand name Baymedix™. These include Baymedix™ CL lubricious coatings, the active-ingredient-releasing Baymedix™ CD, and the hydrophilic Baymedix™ CH grades, which are characterised by very high mechanical strength and outstanding hemocompatibility.

With Baymedix™ FR, the company has now developed a new range of environmentally compatible aqueous polyurethane raw materials for functional medical wound dressings. These are based on polyurethane foams with a specific combination of properties and on Platilon® thermoplastic polyurethane films which are water-vapor permeable and allow the wound to breathe.

The Baymedix™ range also includes Baymedix™ AT topical tissue adhesives that are currently in development. These products constitute an alternative to stitching materials for medical wound closure.

In addition to covering the existing product lines, the new trade name will also be applied to materials designed to meet specialised medical needs. Customized products are an important component of Bayer MaterialScience’s growth strategy for the medical market.

At the core of the Baymedix™ family of products is Bayer MaterialScience’s decades-long experience as a leader in polyurethanes and polycarbonates. With the new brand name, Bayer MaterialScience underscores its commitment to providing solutions to the medical device industry. Part of this commitment is the decision to establish an in-house development and application center and to set up dedicated production lines.

"We want to build a strong brand identity around all our various materials activities in the medical device market," explained Chris Koppenborg, an expert in medical products at Bayer MaterialScience. "We want the Baymedix™ name to become synonymous with service, quality, and innovation in this industry."

While Bayer MaterialScience has a decades-long history of supplying medical-grade thermoplastic resins such as Makrolon® polycarbonate and Texin® thermoplastic polyurethane, the Baymedix™ name refers to its new biomaterials segment. The company intends to aggressively grow this coatings-related medical business in the next few years through new product launches, increased marketing, and enhanced customer support.